MIT Media Lab graduate student Artem Dementyev has created a palm-sized robot with suction-cup feet, known as SkinBot, which can crawl along the body, writes Douglas Heaven of New Scientist. The robot was designed to “carry out a medical inspection of a patient when there is no doctor nearby or when it would be too dangerous for a doctor to approach,” explains Heaven.
MIT researchers have developed a machine learning system that could reduce the number of chemotherapy and radiotherapy treatments that glioblastoma patients receive, reports the Xinhua News Agency. The system “finds an optimal treatment plan, with the lowest possible potency and frequency of doses that should still reduce tumor sizes,” Xinhua explains.
Researchers from MIT’s Little Devices Lab have developed Lego-like devices that can perform diagnostic tests, writes UPI reporter Allen Cone. The devices could significantly reduce the cost of diagnostic tests and as they don't require refrigeration or special handling, “they could be particularly useful in the developing world.”
Empatica, a startup co-founded by Prof. Rosalind Picard, is hoping to use the same data gathered by its wearable device Embrace, which “analyzes physiological signals to detect seizures,” to help people manage stress, reports Rina Raphael of Fast Company. “We’re developing the applications that can help people understand stress,” says Picard, “the technology is there.”
Fast Company reporter Adele Peters writes that MIT researchers have designed a kit that allows scientists to develop diagnostic tests quickly and cheaply. The kit, “uses modular blocks that can be connected in different patterns to replicate the function that would typically be built into a manufactured test for pregnancy, glucose, or an infection or other disease.”
In an article for Salon, Associate Prof. Noelle Eckley Selin and postdoc Sae Yun Kwon discuss their latest research, which examined emissions in China. They write that although mercury pollution is often associated with fish consumption, “China’s future emissions trajectory can have a measurable influence on the country’s rice methylmercury” levels, as well.
In an opinion piece for The Boston Globe, Alex Amouyel, executive director of MIT Solve, explains how the initiative is ‘crowdsolving’ thorny global problems through open innovation. “We need to source ideas from innovators all around the world to find the next breakthroughs,” argues Amouyel. “We know talent and ingenuity exist everywhere.”
Using several comparative models, a new study led by MIT researchers reveals that China’s pledge to peak its carbon emissions by 2030 could cut down on as many as 160,000 premature deaths. “Politically, the research confirms why Chinese officials have their own internal reasons to cut CO2 even though the U.S. is abandoning Paris and disengaging internationally on climate,” writes Ben Geman for Axios.
A new study finds that a 4% reduction in China's carbon emissions by 2030 could save a total of $464.5 billion in healthcare costs, writes Chase Purdy for Quartz. “We have all these policy goals for a transition toward a more sustainable society,” says Associate Prof. Noelle Selin. “Mitigating air pollution, a leading cause of death, is one of them, and avoiding dangerous climate change is another.”
TechCrunch’s Devin Coldewey profiles ReviveMed, a biotech startup out of MIT that turns drug discovery into a big data problem. “ReviveMed’s approach is a fundamentally modern one that wouldn’t be possible just a few years ago, such is the scale of the data involved,” writes Coldeway.
Prof. Hugh Herr and his team in the Biomechatronics Group are developing prosthetics that “respond to neural commands with the flexibility and speed of regular limbs,” writes Eillie Anzilotti for Fast Company. In a process pioneered by the group, “doctors leave the tendons and nerve endings intact so they can continue to feed sensations down past where the human leg ends,” Anzilotti says.
James Gallagher of BBC News speaks with several experts about the microbiome and how diversity in gut bacteria is essential to health. “One thing that we're learning is, based on the microbiome, different people may need to consume different diets in order to get the same effect,” says Prof. Eric Alm.
Synlogic, founded by Prof. Jim Collins and Associate Prof. Tim Lu, is programming probiotic bacteria to treat certain genetic or acquired metabolic disease, reports Robin Seaton Jefferson for Forbes. One product is used for people whose bodies can’t maintain a healthy level of ammonia and “has been specifically engineered to convert the excess ammonia to a harmless metabolite,” explains Seaton Jefferson.
Research led by Prof. Amy Finkelstein found that just 4% of “bankruptcy filings by non-elderly adults” were associated with medical expenses. “Medical bankruptcy…wasn’t nearly as common as anticipated,” writes Alex Kingsbury for The Boston Globe. “Public policy aimed at fighting it might not have the anticipated results, either.”
A study co-authored by researchers at MIT finds that hospitalizations only cause about 4 percent of bankruptcies among nonelderly adults in the U.S., reports Tom Murphy of the Associated Press. Researchers gathered data from “more than a half million adults under 65 in California who had a hospitalization between 2003 and 2007 that wasn't tied to childbirth.”